SentryX will be attending BioEquity Europe 2025.

Our CEO, Bas Oosterman, together with VP Business Development, Floris van Tol, are looking forward to connect with industry partners and share our latest developments on implantable anesthetics. We are excited to discuss our roadmap for bringing this technology to patients.

If you are around and want to connect, please don’t hesitate to reach out!